Statement Of Changes In Equity [Abstract]

Xbrane Biopharma - Filing #702449

Concept As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
713 313 SEK
431 741 SEK
1 134 276 SEK
5 165 SEK
5 614 SEK
524 938 SEK
4 977 SEK
3 945 SEK
773 724 SEK
257 708 SEK
184 323 SEK
3 456 SEK
6 719 SEK
448 089 SEK
159 352 SEK
6 719 SEK
298 912 SEK
448 089 SEK
3 456 SEK
273 941 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
188 376 SEK
188 376 SEK
226 026 SEK
226 026 SEK
Other comprehensive income
1 220 SEK
1 220 SEK
2 774 SEK
2 774 SEK
Comprehensive income
1 220 SEK
187 156 SEK
188 376 SEK
228 800 SEK
226 026 SEK
2 774 SEK
Issue of equity
356 005 SEK
633,000 SEK
356 638 SEK
325 860 SEK
1 519 SEK
324 342 SEK
Increase through other contributions by owners, equity
380 237 SEK
633,000 SEK
380 870 SEK
346 444 SEK
1 519 SEK
344 926 SEK
Decrease through other distributions to owners, equity
24 231 SEK
24 231 SEK
20 584 SEK
20 584 SEK
Increase (decrease) through other changes, equity
24 970 SEK
24 970 SEK
Increase (decrease) through share-based payment transactions, equity
4 547 SEK
4,000 SEK
4 551 SEK
1 296 SEK
3,000 SEK
1 293 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.